German firm Miltenyi Biotec on Tuesday announced the launch of operations in India with the opening of an office in Hyderabad and further plans to invest in a first-of-its-kind Cell and Gene Therapy centre of excellence for Indian academia and industry.
Scientists, researchers, industry experts and clinicians can get classroom to hands-on training on cell and gene therapy (CGT) approaches, from proof of concept to pre-clinical / clinical development and commercialisation, at the CoE. The centre will also provide Indian researchers, scientists and clinicians easier access to expertise, research and manufacturing solutions, according to the firm, which is a global provider of products and services that empower biomedical discovery and advance cellular therapy.
The announcement of the office opening and the proposed CoE was made at BioAsia 2024 in the presence of Chief Minister A. Revanth Reddy; Board Member Miltenyi Biotec B.V. & Co. KG and managing director Boris Stoffel; Miltenyi Biomedicine MD Toon Overstijns; and MD-India and Area Head India and Southeast Asia Annapurna Das.